Loading
A phase 3 trial of Filgrastim, Amsacrine, Carmustine, Cytarabine, Etoposide, Idarubicin and Mitoxantrone in Leukaemia, run by European Organisation for Research and Treatment of Cancer - EORTC, completed.
Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia is a phase 3 interventional study registered as NCT00002719 by European Organisation for Research and Treatment of Cancer - EORTC, with 500 participants recorded, started 1995-12 and reaching its primary completion in 2001-11. Interventions recorded: filgrastim, amsacrine, carmustine, cytarabine, etoposide, idarubicin, mitoxantrone hydrochloride, peripheral blood stem cell transplantation. Conditions recorded: Leukemia, Neutropenia.
Linked to the drug Amsacrine because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
Shares Amsacrine, Idarubicin, Mitoxantrone, Filgrastim (G-CSF) and the tag pipeline.
Shares Amsacrine, Mitoxantrone, Cytarabine, Etoposide and the tag pipeline.
Shares Mitoxantrone, Cytarabine, Etoposide, Leukaemia (all types) and the tag pipeline.
Shares Idarubicin, Mitoxantrone, Cytarabine and the tag pipeline.
Shares Mitoxantrone, Cytarabine, Etoposide, Leukaemia (all types) and the tag pipeline.
Shares Mitoxantrone, Cytarabine, Etoposide and the tag pipeline.
Shares Filgrastim (G-CSF), Cytarabine, Etoposide, Leukaemia (all types) and the tag pipeline.
Shares Idarubicin, Cytarabine and the tag pipeline.